Clinical Trials

Phase I/II Randomized Study of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) With Versus Without Etoposide in Older Patients With Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin’s Lymphoma

France

OBJECTIVE: Compare the complete response rates and overall survival in older patients with diffuse large B-cell or peripheral T-cell non-Hodgkin’s lymphoma treated with CHOP with vs without etoposide.

ELEGIBILITY REQUIREMENTS: Diagnosis of diffuse large B-cell or peripheral T-cell non-Hodgkin’s lymphoma. Age 70 and over. No history of concurrent severe disease or other concurrent use of antineoplastic agents.

CONTACT INFORMATION:
EORTC Lymphoma Group
Pierre Soubeyran MD PH: 33-5-56-33-32-67
Soubeyran_p@bergonie.org
Bordeaux, FRANCE

8am to 5pm EST